Pay in 4 interest-free payments of $5.51 Learn more
Ships within 48 hours · Estimated delivery Aug 18 - Aug 23
Support Cardiovascular System - Elevated levels of LDL or oxidised lipids increases the risk of cardiovascular disorders and heart attacks
Follow up appointments are scheduled to check in with your provider to see how you are doing
While preliminary data suggest a potential association, further studies are needed to fully understand the mechanisms at play and to develop strategies for minimizing UTI risk in patients using semaglutide
If pregnant, consult healthcare practitioner before use
Broadest Phase 3 readout program
Oral administration of PF-06882961 shows evidence of glucose-lowering in healthy human study participants PF-06882961 was selected as a candidate for clinical studies based on its in vitro and in vivo pharmacologic and disposition profile, including potent agonism of the GLP-1R, preclinical disposition attributes (e.g., low metabolic CL int in human hepatocytes), good safety margins versus the hERG channel (IC 50 = 4.3 M, Table S4) and broad panel screening (Table S8), and selectivity versus related class B GPCRs (Table S9)
US$ 27.75
US$ 26.88
US$ 26.83
US$ 28.82
US$ 23.01
US$ 24.60
US$ 25.85
